|
|||||
|
|
Leveraging genetic predictors of factor XI levels to anticipate results from clinical trials |
|
| Authors: | Iyas Daghlas Dipender Gill |
| Affiliation: | 1. Department of Neurology, University of California San Francisco, San Francisco, California, USA;2. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK |
| Abstract: | |
| Keywords: | factor XI FXI Mendelian randomization stroke venous thromboembolism |